The U.S. precision medicine market reached USD 38.4 Billion in 2024. IMARC Group forecasts it will grow to USD 43.2 Billion by 2033, at a CAGR of 11.7% from 2025 to 2033, driven by advancements in genomics, targeted therapies, and rising demand for personalized, efficient healthcare solutions. https://www.imarcgroup.com/united-states-precision-medicine-market